ArticleAJPM focus2025
Novel Platforms of Education to Engage Black and African Americans in Lung Cancer Screening.
Article in AJPM focus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Black and African Americans face a higher risk and greater mortality from lung cancer than other racial groups. Despite the proven benefits of lung cancer screening, Black and African Americans, who derive even greater benefit from screening than other races, are less likely to participate. This study aims to increase the uptake of lung cancer screening by employing novel platforms for patient-centered education and engagement. Methods: In an urban, safety-net health institution, the authors utilized existing relationships with patients and clinical sites to disseminate patient-oriented information about lung cancer and screening through in-person education events, virtual community meetings, and patient story videos and recordings from January 2020 to December 2022. Outcome measures included the number of lung cancer screenings from January 2013 to December 2023 and adherence to annual follow-up from January 2014 to December 2022. Results: Lung cancer screening increased from 739 in 2020 to 2,067 in 2022, with 30.6% conducted among Black and African American patients. However, adherence to annual screening remains low, with 27.2% adhering to 1 annual screen, 7.1% adhering to 2 annual screens, and 6.6% adhering to 3 or more consecutive screens in 2022. Black and African Americans were significantly less likely to adhere to 1 and 3 or more annual lung cancer screenings. Conclusions: The utilization of multiple platforms to disseminate lung cancer screening education and engagement may have a positive impact on overall screening uptake among Black and African Americans. However, additional interventions must be devised to address low adherence to annual screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.